INTENT Biologics, a clinical-stage biotechnology company developing PEP Biologic as the first-in-class exosome-based biologic therapies for serious conditions with significant unmet medical need, ...
ROCHESTER, Minn.--(BUSINESS WIRE)--( plated )â„¢ Skin Science, a breakthrough skincare brand powered by exosome science, today announced the opening of its new 14,000 square foot manufacturing facility ...
At the Mayo Clinic, Dr. Guifang Zhao is leading a new generation of regenerative medicine therapies that combine the precision of gene-based design with the bod ...
Exosomes Produced in the Liquid Media of the BioHarvest Unique Large-Scale Bioreactors Add Potential New Revenue Stream from Products and CDMO Opportunities Exosomes are nano-sized extracellular ...
ROCHESTER, Minn.--(BUSINESS WIRE)--RION, a clinical-stage regenerative medicine company at the forefront of exosome therapeutics, announced today the first subject was dosed in the Phase 2 clinical ...
Exosome-associated THSD7A is identified as a key trigger of filopodia formation in cancer cells and neurons, revealing a ...
TAIPEI, Dec. 30, 2025 /PRNewswire/ -- TOMO YUME Group today announced that its subsidiary, Sparkling Sciences, a leader in exosome research and development, has successfully obtained dual ...
This combination will create synergistic effects to boost the commercialization of exosome technology around the world. ExoCoBio will continue to support all the business activities currently engaged ...
Exosomes Produced in the Liquid Media of the BioHarvest Unique Large-Scale Bioreactors Add Potential New Revenue Stream from Products and CDMO Opportunities Rehovot, Israel--(Newsfile Corp. - ...